Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Pre-market
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverSIBN
HealthcareNGMUSD

SI-BONE, Inc.

$0012345678900123456789.0012345678900123456789+0.9%
52w low (est.) $13.40$20.83 52w high (est.)
Market data · updated 1h ago
Market data
Market cap
USD770.79M
52w range
USD11.48 - USD21.89
Beta
0.67
Sector
Healthcare
Data quality
83/100
Valuation
DCF fair value
USD6.95
Margin of safety
-58.2%
Quality & efficiency
Moat score
45/100
Return on equity
-9.6%
Profit margin
-8.1%
Debt / equity
0.24
Growth & analysts
Revenue growth
+11.2%
Analyst target
USD24.13
Target upside
+45.2%
Analysts
8
Run the 10-point checklist before you buy How these numbers are made

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Valuation

ValueGrowthProfitHealthIncome28QUALITY
Overall Rating
29
Sell
Sell

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score45
DCF Intrinsic Value
USD6.95-58.2% downside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
USD770.79M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
+11.2%
Profit Margin
-8.1%
ROE
-9.6%
Debt / Equity
0.24
Beta
0.67
vs Healthcare sector:Moat 45 vs 7Yield 0.00% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · SIBN